LLC Insight Holdings Group Purchases Shares of Hinge Health
Insight Holdings Group acquired 1.47 million shares of Hinge Health on June 29, 2026.
Key Points
- LLC Insight Holdings Group bought 1.47 million shares of Hinge Health, Inc. (HNGE) on June 29, 2026, indicating a significant insider transaction.
- Shares of Hinge Health traded near $78.97 on Tuesday, with a market cap of approximately $6.11 billion and a forward P/E ratio of 23.5.
- Analysts from firms like Wells Fargo and Raymond James maintain a 'buy' rating, with price targets ranging from $70 to $90.
Important disclosure: Podchat is not a registered investment adviser, broker-dealer, or financial planner. This article is for informational and educational purposes only and is not a recommendation to buy, sell, or hold any security. Content may be generated by automated systems using public filings, market data, and third-party sources, and may contain errors or omissions. Investing involves risk, including possible loss of principal. Past performance, insider activity, analyst ratings, price targets, sentiment scores, and hypothetical or backtested results are not guarantees of future performance. Please do your own research and consult a qualified professional before making investment decisions.
On June 29, 2026, LLC Insight Holdings Group made a significant move by purchasing 1,466,667 shares of Hinge Health, Inc. (NYSE: HNGE). This insider transaction highlights the group's interest in the healthcare technology company, which focuses on musculoskeletal system care.
Other Institutional Activity in Hinge Health
Several other institutional investors have also been active in Hinge Health. Deer Management Co. LLC opened a new position with 2,633,707 shares, valued at about $101.6 million. Meanwhile, RTW Investments, LP increased its holdings by 1,576,500 shares, achieving a total of 1,930,000 shares worth approximately $74.4 million, marking a 446% increase. Bit Capital GmbH reduced its position by 1,006,304 shares, ending with 2,309,797 shares valued at $89.1 million, reflecting a 30.3% decrease.
Hinge Health, Inc. Stock Down 6.7%
Shares of Hinge Health traded near $78.97 on Tuesday. The company has a market cap of around $6.11 billion and a forward P/E ratio of 23.5. Its stock has seen a 52-week low of $30.08 and a high of $79.26, with a 50-day moving average of $56.38 and a 200-day moving average of $48.25. Hinge Health carries a current ratio of 1.30, a quick ratio of 1.04, and a debt-to-equity ratio of 2.24.
$HNGE stock price
Daily closing prices, year to date. Not investment advice.
Recent Earnings
Hinge Health reported revenue of $646.3 million, with a growth rate of 47.2%. Despite this growth, the company posted a net margin of -78.9% and a return on equity of -136.0%, indicating challenges in profitability. The next earnings report is expected on August 4, 2026.
Insider Buying and Selling at Hinge Health, Inc.
Insight Holdings Group has been active in trading Hinge Health shares. On June 29, 2026, the group purchased 1,466,667 shares. Previously, on June 25, 2026, they bought 530,982 shares. These transactions were not under a Rule 10b5-1 plan, indicating a strategic interest in the company.
Analysts Set New Price Targets
Analysts continue to show confidence in Hinge Health. On June 24, 2026, Wells Fargo maintained its 'buy' rating with a $90 price target. Other analysts, like those from Raymond James and Keybanc, also reaffirmed their 'buy' ratings, with targets of $80 and $90, respectively. The overall analyst consensus remains a 'buy', with an average target price of $82.07 based on 15 opinions.
About Hinge Health
Hinge Health, Inc., headquartered in San Francisco, California, is a healthcare technology company that focuses on musculoskeletal system care. Founded in 2012, the company uses technology to automate and scale the delivery of care, serving primarily self-insured employers. Its platform includes AI-powered motion tracking and a proprietary wearable device for personalized care.
Bottom Line
LLC Insight Holdings Group's recent share purchase in Hinge Health reflects its strategic interest in the company. Hinge Health's stock performance and analyst ratings suggest continued confidence in its potential. However, investors should note that insider transactions like these are backward-looking indicators and may not reflect current positions or future performance.
Get Hinge Health, Inc. alerts
New 13F filings, insider trades, and analyst moves on $HNGE, sent to your inbox. Free, and you can unsubscribe anytime.
This instant news alert was generated by automated narrative technology and financial data from Podchat and public regulatory filings. It is for informational purposes only and is not financial advice.